188
Participants
Start Date
January 31, 2022
Primary Completion Date
October 10, 2023
Study Completion Date
May 30, 2025
Medtronic Implantable Tibial Neuromodulation (TNM) System
Stimulation of the tibial nerve using Medtronic's tibial neuromodulation device.
Stony Brook University Hospital, Stony Brook
Associated Medical Professionals, Syracuse
Chesapeake Urology Associates, Towson
Alliance Urology Specialists, Greensboro
Atrium Health Carolinas Medical Center, Charlotte
FirstHealth Urogynecology, Hamlet
Prisma Health, Greenville
Georgia Urology, Cartersville
Urology Centers of Alabama, Homewood
The Ohio State University Wexner Medical Center, Columbus
Central Ohio Urology Group, Gahanna
Wright State Physicians, Fairborn
Urology Partners of North Texas Research Institute, Arlington
Michigan Institute of Urology, Troy
Henry Ford Health System, Detroit
Mercy Health Saint Mary's, Grand Rapids
University of Iowa Hospitals and Clinics, Iowa City
Ascension Columbia St. Mary's, Milwaukee
Minnesota Urology, Plymouth
Mayo Clinic Urology, Rochester
Sanford Female Pelvic Medicine & Reconstructive Surgery Clinic, Sioux Falls
Northwestern Medicine, Chicago
Providea Health Partners, Evergreen Park
Louisiana State University Health Sciences Center, New Orleans
Urology Surgeons of Oklahoma, Oklahoma City
University of Texas Medical Branch, Galveston
Virginia Mason Medical Center, Seattle
Summit Health Englewood, Englewood
Summit Health Voorhees, Voorhees Township
Lead Sponsor
MedtronicNeuro
INDUSTRY